Mixed Dyslipidemia: Clinical Trials

6 trials for Mixed Dyslipidemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 not yet recruiting, 1 recruiting. 6 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 16Completed 3, Not yet recruiting 2, Recruiting 1

Follow Mixed Dyslipidemia: new trials by email Literature Review of Mixed Dyslipidemia trials Research Report on Mixed Dyslipidemia

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Effect of Food on the Pharmacokinetic Characteristics and Safety Profile of AD-117 in Healthy Adult Volunteers
AD-117 - Mixed Dyslipidemia, Food Effect Study of AD-117
Phase 1CompletedAddpharma Inc.602026-02-102026-07-15
A Study to Compare to PK Characteristics and Safety Profiles Between AD-117 and AD-117A
AD-117, AD-117A - Mixed Dyslipidemia
Phase 1Not yet recruitingAddpharma Inc.602025-12-012025-12-04
Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics of DW5124 and DW5124-R, and the Effect of Food on DW5124 in Healthy Adult Volunteers
DW5124, DW5124-R - Mixed Dyslipidemia
Phase 1CompletedDaewon Pharmaceutical Co., Ltd.552025-05-082026-01-06
The Food Effect on PK Characteristics and Safety Profiles of PA-111
PA-111 - Mixed Dyslipidemia
Phase 1Not yet recruitingAddpharma Inc.402025-05-012025-05-16
A Study to Compare to PK Characteristics and Safety Profiles Between PA-111 and PA-111A
PA-111, PA-111A - Mixed Dyslipidemia
Phase 1RecruitingAddpharma Inc.482025-04-012025-04-17
Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab
Evolocumab - Hyperlipidemia, Mixed Dyslipidemia
Phase 1CompletedAmgen182014-08-192022-11-07

Narrower conditions

Hyperlipidemias (1)  ·  Kidney Failure, Chronic (1)  ·  Renal Insufficiency (1)

Broader conditions

Chronic Disease (1)  ·  Disease Attributes (1)  ·  Dyslipidemias (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Kidney Diseases (1)  ·  Lipid Metabolism Disorders (1)  ·  Male Urogenital Diseases (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Renal Insufficiency, Chronic (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

evolocumab (1)

Sponsors

Addpharma Inc. (4)  ·  Amgen (1)  ·  Daewon Pharmaceutical Co., Ltd. (1)

Countries

South Korea (5)  ·  United States (1)